Across TCGA pan-cancer cohorts, PPIAP89 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated PPIAP89 data layer.
The strongest signal is observed in stomach adenocarcinoma (STAD), where higher PPIAP89 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated PPIAP89 expression acts as an unfavorable survival marker, although some lineages such as LUAD and SKCM show a favorable association.
STAD, BRCA, and UVM are the cancer types where PPIAP89 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.